Skip to main content
Article

The application of real-time indocyanine green fluorescence cholangiography in laparoscopic living donor left lateral sectionectomy

Lu LuHepatobiliary Surgery Center, Department of General Surgery, Huashan Hospital, Fudan University, Shanghai, ChinaWenwei ZhuHepatobiliary Surgery Center, Department of General Surgery, Huashan Hospital, Fudan University, Shanghai, ChinaConghuan ShenLiver Transplantation Center, Department of General Surgery, Huashan Hospital, Fudan University, Shanghai, ChinaYifeng TaoLiver Transplantation Center, Department of General Surgery, Huashan Hospital, Fudan University, Shanghai, ChinaZhengxin WangLiver Transplantation Center, Department of General Surgery, Huashan Hospital, Fudan University, Shanghai, ChinaJinhong ChenHepatobiliary Surgery Center, Department of General Surgery, Huashan Hospital, Fudan University, Shanghai, ChinaLun–Xiu QinHepatobiliary Surgery Center, Department of General Surgery, Huashan Hospital, Fudan University, Shanghai, China
2024en
ABI

Abstract

Background: The judgment of the division point of the bile duct has always been one of the difficulties of laparoscopic left lateral sectionectomy (LLLS). The purpose of this study was to assess the effects of indocyanine green (ICG) fluorescence cholangiography during LLLS on the occurrence of biliary complications in both donors and recipients. The optimal dose and injection time of ICG were also investigated. Methods: This is a retrospective cohort study. From October 2016 to December 2022, the clinical data of 103 donors who underwent LLLS and relevant recipients were retrospectively analyzed. According to whether ICG fluorescence cholangiography was used, they were divided into a non-ICG group (n=46) and an ICG group (n=57). Biliary complications were observed and the optimal dose and injection time of ICG were explored. Results: 0.078±0.022, P=0.021). Conclusions: ICG fluorescence cholangiography is safe and feasible in LLLS. It reduces biliary complications in both donors and recipients. The optimal ICG dose was 0.004 mg/kg, and 90 minutes after injection was the best observation time. ICG fluorescence cholangiography is recommended for routine use in LLLS.

Identifiers

Citations and references

Cited by 20 references